Maintenance Intravenous Immunoglobulin Treatment for Multiple Sclerosis Coexisting with Ehlers-Danlos Syndrome and Muir-Torre Syndrome: A Case Study

The therapeutic options for disease modification in relapsing-remitting multiple sclerosis (RRMS) have expanded remarkably in the last 15 years. Although intravenous immunoglobulins (IVIg) have shown some therapeutic effects in multiple sclerosis, reducing global supplies, restriction of treatment t...

Descripción completa

Detalles Bibliográficos
Autores principales: Gupta, Srishti, Suri, Mohnish, Constantinescu, Cris S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7606394/
https://www.ncbi.nlm.nih.gov/pubmed/32780270
http://dx.doi.org/10.1007/s40120-020-00209-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7606394/
https://www.ncbi.nlm.nih.gov/pubmed/32780270
http://dx.doi.org/10.1007/s40120-020-00209-0

Ejemplares similares